Review Article
Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives
Table 10
Polymeric micelles in clinical trials.
| Polymeric micelle | Block copolymer | Drug | Diameter (nm) | Indication | Clinical phase |
| NK012 | PEG-PGlu(SN-38) | SN-38 | 20 | Breast cancer | II | NK105 | PEG-P(aspartate) | Paclitaxel | 85 | Advanced stomach cancer | II | SP1049C | Pluronic L61 and F127 | Doxorubicin | 22–27 | Adenocarcinoma of esophagus, gastro esophageal junction and stomach | III | NC-6004 | PEG-PGlu(cisplatin) | Cisplatin | 30 | Solid tumors | I/II | | | | | Breast cancer | I | | | | | Pancreatic cancer | V | Genexol-PM | PEG-P(D,L-lactide) | Paclitaxel | 20–50 | Non-small-cell lung cancer in combination with carboplatin |
II | | | | | Pancreatic cancer in combination with gemcitabine |
I/II | | | | | Ovarian cancer in combination with carboplatin |
|
|